(1) Background: We proposed to review worldwide estimates of cognitive impairment
prevalence and incidence in adults older than 50 years of age living in the community.(2) …

Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by deficits in
episodic memory, working memory (WM), and executive function. Examples of executive …

Objective To update the 2001 American Academy of Neurology (AAN) guideline on mild
cognitive impairment (MCI). Methods The guideline panel systematically reviewed MCI …

This report discusses the public health impact of Alzheimer's disease (AD), including
incidence and prevalence, mortality rates, costs of care and the overall effect on caregivers …

Importance Growing evidence suggests an association between sleep-disordered breathing
(SDB) and cognitive decline in elderly persons. However, results from population-based …

The construct of mild cognitive impairment (MCI) has evolved over the past 10 years since
the publication of the new MCI definition at the K ey S ymposium in 2003, but the core …

This report discusses the public health impact of Alzheimer's disease (AD), including
incidence and prevalence, mortality rates, costs of care, and overall effect on caregivers and …

With the aging of the population, the burden of Alzheimer's disease (AD) is rapidly
expanding. More than 5 million people in the US alone are affected with AD and this number …

This report provides information to increase understanding of the public health impact of
Alzheimer's disease (AD). Topics addressed include incidence, prevalence, mortality rates …

Mild cognitive impairment (MCI) is the widely used term that describes an intermediate stage
from normal cognitive function to dementia. The concept of MCI is highly significant and …